Quarterly Results • Search Archive
Piramal Pharma Limited
Results, Financials & Updates
Follow Piramal Pharma Limited results and financial updates in one company page: latest revenue or income, profit, margins, quarter comparisons, what changed and detailed Nivata Results deep dives.
1 published deep dive
1 quarter 1 sector
Company Overview
Piramal Pharma Limited: latest results and financials
About the business in Nivata's latest coverage
Piramal Pharma Limited operates as a leading global pharmaceutical, health, and wellness company, offering a comprehensive portfolio of differentiated products and services across 17 global development and manufacturing facilities and a worldwide distribution network reaching over 100 countries. The company's operational structure is anchored by three primary business segments: Contract Development and Manufacturing Organization (CDMO) operating under Piramal Pharma Solutions, Complex Hospital Generics (CHG) operating under Piramal Critical Care, and Piramal Consumer Healthcare (PCH) selling over-the-counter consumer and wellness brands.
Quarter history
Piramal Pharma Limited Results & Financials
Latest Nivata coverage: Q2 FY27 · revenue ₹2,617.06 Cr · PAT ₹5.03 Cr.
Nivata currently has one covered quarter for this company. This page remains the stable company-results hub and expands automatically as additional quarters are published.